S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
66,000% upside on tiny biotech? (Ad)
MarketBeat Week in Review – 9/18 - 9/22
The federal government is headed into a shutdown. What does it mean, who's hit and what's next?
66,000% upside on tiny biotech? (Ad)
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
Auto workers still have room to expand their strike against car makers. But they also face risks
66,000% upside on tiny biotech? (Ad)
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
66,000% upside on tiny biotech? (Ad)
MarketBeat Week in Review – 9/18 - 9/22
The federal government is headed into a shutdown. What does it mean, who's hit and what's next?
66,000% upside on tiny biotech? (Ad)
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
Auto workers still have room to expand their strike against car makers. But they also face risks
66,000% upside on tiny biotech? (Ad)
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
66,000% upside on tiny biotech? (Ad)
MarketBeat Week in Review – 9/18 - 9/22
The federal government is headed into a shutdown. What does it mean, who's hit and what's next?
66,000% upside on tiny biotech? (Ad)
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
Auto workers still have room to expand their strike against car makers. But they also face risks
66,000% upside on tiny biotech? (Ad)
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
66,000% upside on tiny biotech? (Ad)
MarketBeat Week in Review – 9/18 - 9/22
The federal government is headed into a shutdown. What does it mean, who's hit and what's next?
66,000% upside on tiny biotech? (Ad)
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
Auto workers still have room to expand their strike against car makers. But they also face risks
66,000% upside on tiny biotech? (Ad)
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
NASDAQ:BCYC

Bicycle Therapeutics (BCYC) Institutional Ownership

$20.09
-1.46 (-6.77%)
(As of 09/22/2023 ET)
Compare
Today's Range
$20.09
▼
$21.75
50-Day Range
$20.09
▼
$25.82
52-Week Range
$18.84
▼
$33.49
Volume
313,674 shs
Average Volume
350,666 shs
Market Capitalization
$603.50 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$48.75
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

Institutional Ownership Changes (13F Filings) for Bicycle Therapeutics (NASDAQ:BCYC)

Current
Institutional Ownership
Percentage
86.15%
Number of
Institutional Buyers
(last 12 months)
49
Total
Institutional Inflows
(last 12 months)
$77.71 M
Number of
Institutional Sellers
(last 12 months)
36
Total
Institutional Outflows
(last 12 months)
$90.74 M
Get BCYC Insider Trade Alerts

Want to know when executives and insiders are buying or selling Bicycle Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

BCYC Institutional Buying and Selling by Quarter


Bicycle Therapeutics Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/21/2023Osaic Holdings Inc.2,320$59K0.0%+118.9%0.008%
8/15/2023Fishman Jay A Ltd. MI20,500$0.52M0.1%+95.2%0.068%
8/15/2023Goldman Sachs Group Inc.18,215$0.47M0.0%+72.7%0.061%
8/15/2023Point72 Asset Management L.P.478,000$12.20M0.0%-40.4%1.591%
8/15/2023Kennedy Capital Management LLC123,188$3.14M0.1%N/A0.410%
8/15/2023Boothbay Fund Management LLC42,133$1.08M0.0%-49.3%0.140%
8/14/2023Tower Research Capital LLC TRC 2,420$62K0.0%+91.6%0.008%
8/14/2023Schonfeld Strategic Advisors LLC66,100$1.69M0.0%+10.0%0.220%
8/14/2023Marshall Wace LLP9,271$0.24M0.0%-87.9%0.031%
8/14/2023State Street Corp8,666$0.22M0.0%N/A0.029%
8/14/2023Bellevue Group AG25,000$0.64M0.0%-53.0%0.083%
8/14/2023UniSuper Management Pty Ltd113,458$2.90M0.0%N/A0.378%
8/14/2023Polar Capital Holdings Plc759,500$19.38M0.1%-24.8%2.528%
8/14/2023Prelude Capital Management LLC9,061$0.23M0.0%-28.3%0.030%
8/11/2023Renaissance Technologies LLC70,900$1.81M0.0%+14.5%0.236%
8/11/2023Natixis2,775$70K0.0%-18.4%0.009%
8/11/2023BlackRock Inc.181,108$4.62M0.0%+1.2%0.603%
8/11/2023JPMorgan Chase & Co.96,151$2.45M0.0%+10.3%0.320%
8/11/2023ExodusPoint Capital Management LP111,973$2.86M0.0%-8.8%0.373%
8/10/2023Osaic Holdings Inc.2,320$59K0.0%+118.9%0.008%
8/10/2023Tekla Capital Management LLC44,338$1.13M0.0%-50.0%0.148%
8/8/2023Candriam S.C.A.1,273,261$32.49M0.2%-2.3%4.239%
8/2/2023Handelsbanken Fonder AB134,500$3.43M0.0%+2.0%0.448%
7/25/2023DekaBank Deutsche Girozentrale30,000$0.72M0.0%+127.3%0.100%
7/20/2023Exchange Traded Concepts LLC5,276$0.14M0.0%N/A0.018%
7/18/2023AtonRa Partners14,219$0.36M0.6%-6.3%0.047%
7/11/2023Harbor Capital Advisors Inc.21,045$0.54M0.1%+10.0%0.070%
7/7/2023Woodstock Corp20,553$0.53M0.1%+10.3%0.068%
6/1/2023Prelude Capital Management LLC12,634$0.27M0.0%N/A0.059%
5/18/2023JPMorgan Chase & Co.87,138$1.85M0.0%+4.7%0.409%
5/16/2023Jane Street Group LLC9,800$0.21M0.0%N/A0.046%
5/16/2023First Light Asset Management LLC699,328$14.88M1.3%+0.4%3.282%
5/16/2023Armistice Capital LLC736,000$15.66M0.2%N/A3.455%
5/15/2023Schonfeld Strategic Advisors LLC60,100$1.28M0.0%-24.6%0.282%
5/15/2023Cubist Systematic Strategies LLC43,807$0.93M0.0%+232.1%0.206%
5/15/2023Logos Global Management LP750,000$15.95M2.3%-47.7%3.520%
5/15/2023Two Sigma Advisers LP187,900$4M0.0%+16.1%0.882%
5/15/2023Two Sigma Investments LP160,576$3.42M0.0%N/A0.754%
5/15/2023Price T Rowe Associates Inc. MD318,076$6.77M0.0%-6.1%1.493%
5/15/2023AXA S.A.460,125$9.79M0.0%+20.9%2.160%
5/15/2023Rubric Capital Management LP205,423$4.37M0.1%N/A0.964%
5/15/2023Sio Capital Management LLC967,347$20.58M10.2%+41.5%4.540%
5/12/2023Renaissance Technologies LLC61,900$1.32M0.0%N/A0.291%
5/12/2023Candriam S.C.A.1,303,211$25.51M0.2%+10.9%6.117%
5/12/2023BlackRock Inc.178,932$3.81M0.0%-5.7%0.840%
5/12/2023BNP Paribas Arbitrage SNC7,279$0.16M0.0%+4,393.2%0.034%
5/12/2023UBS Group AG13,892$0.30M0.0%+7.3%0.065%
5/11/2023FMR LLC287,147$6.11M0.0%-24.0%1.348%
5/11/2023ExodusPoint Capital Management LP122,781$2.61M0.0%+17.1%0.576%
5/5/2023AtonRa Partners15,169$0.32M0.5%-11.1%0.071%
5/3/2023Jump Financial LLC37,737$0.80M0.0%+410.0%0.177%
4/26/2023Harbor Capital Advisors Inc.19,132$0.41M0.1%-20.8%0.090%
4/6/2023Woodstock Corp18,630$0.40M0.1%+25.5%0.087%
2/28/2023Voya Investment Management LLC66,040$1.96M0.0%-2.5%0.310%
2/24/2023Natixis3,613$0.11M0.0%N/A0.017%
2/16/2023Alliancebernstein L.P.72,549$2.15M0.0%+14.4%0.244%
2/15/2023Schonfeld Strategic Advisors LLC79,746$2.36M0.0%+283.4%0.269%
2/15/2023Soleus Capital Management L.P.258,400$7.65M1.1%N/A0.870%
2/15/2023Legal & General Group Plc10,533$0.31M0.0%+15.3%0.035%
2/15/2023Millennium Management LLC168,723$4.99M0.0%+18.0%0.568%
2/15/2023Morgan Stanley721,559$21.36M0.0%-16.1%2.430%
2/15/2023First Light Asset Management LLC696,432$20.61M1.9%-1.2%2.346%
2/14/2023Point72 Asset Management L.P.1,007,978$29.84M0.1%-19.7%3.395%
2/14/2023Vident Investment Advisory LLC23,957$0.71M0.0%N/A0.081%
2/14/2023Price T Rowe Associates Inc. MD338,733$10.03M0.0%-18.8%1.141%
2/14/2023Verition Fund Management LLC380,849$11.27M0.2%+9.3%1.283%
2/14/2023Pura Vida Investments LLC239,015$7.08M0.4%+12.1%0.805%
2/13/2023Deutsche Bank AG8,370$0.25M0.0%-43.6%0.028%
2/13/2023ExodusPoint Capital Management LP104,866$3.10M0.0%+33.3%0.353%
2/13/2023Geode Capital Management LLC17,144$0.51M0.0%-20.0%0.058%
2/13/2023JPMorgan Chase & Co.83,206$2.46M0.0%-33.8%0.280%
2/10/2023Bank of America Corp DE5,513$0.16M0.0%-39.6%0.019%
2/10/2023Victory Capital Management Inc.8,037$0.24M0.0%-77.6%0.038%
2/8/2023UBS Group AG12,942$0.38M0.0%-54.5%0.044%
2/7/2023Handelsbanken Fonder AB131,800$3.90M0.0%+1.4%0.444%
2/7/2023TD Asset Management Inc23,586$0.70M0.0%+51.3%0.079%
2/2/2023AtonRa Partners17,067$0.51M0.6%-21.0%0.057%
1/20/2023Harbor Capital Advisors Inc.24,147$0.72M0.7%-47.1%0.081%
1/17/2023Twelve Points Wealth Management LLC7,200$0.21M0.1%N/A0.024%
11/15/2022Alliancebernstein L.P.63,438$1.48M0.0%-52.1%0.214%
11/15/2022State Street Corp8,822$0.21M0.0%-49.5%0.030%
11/15/2022Two Sigma Advisers LP262,700$6.11M0.0%-36.7%0.885%
11/15/2022Two Sigma Investments LP49,500$1.15M0.0%-87.0%0.167%
11/15/2022Tybourne Capital Management HK Ltd.1,041,331$24.22M2.3%-9.8%3.507%
11/15/2022Price T Rowe Associates Inc. MD417,340$9.71M0.0%-0.9%1.406%
11/15/2022Pura Vida Investments LLC213,121$4.96M0.3%+16.4%0.718%
11/15/2022Parkman Healthcare Partners LLC81,364$1.89M0.5%+34.7%0.274%
11/15/2022Logos Global Management LP2,000,000$46.52M5.7%+17.6%6.736%
11/15/2022Marshall Wace LLP9,271$0.22M0.0%-88.4%0.031%
11/15/2022Ensign Peak Advisors Inc24,033$0.56M0.0%+31.6%0.081%
11/15/2022First Light Asset Management LLC704,721$16.39M1.7%+0.1%2.374%
11/15/2022Bellevue Group AG98,100$2.28M0.0%+16.2%0.330%
11/15/2022BlackRock Inc.181,047$4.21M0.0%-5.3%0.610%
11/15/2022Citadel Advisors LLC48,404$1.13M0.0%-84.6%0.163%
11/14/2022Point72 Asset Management L.P.1,255,418$29.20M0.1%-13.1%4.230%
11/14/2022Verition Fund Management LLC348,513$8.11M0.1%-12.7%1.174%
11/14/2022Samlyn Capital LLC1,294,085$30.10M0.6%+24.4%4.361%
11/14/2022AXA S.A.410,640$9.55M0.0%-11.3%1.384%
11/14/2022UBS Oconnor LLC67,625$1.57M0.0%+17.4%0.228%
11/10/2022ExodusPoint Capital Management LP78,682$1.83M0.0%-56.8%0.265%
(Data available from 1/1/2016 forward)













BCYC Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of BCYC shares?

During the previous two years, 108 institutional investors and hedge funds held shares of Bicycle Therapeutics. The most heavily invested institutionals were Deep Track Capital LP ($81.44M), Eventide Asset Management LLC ($76.91M), Janus Henderson Group PLC ($72.56M), RTW Investments LP ($56M), Frazier Management LLC ($33.80M), Candriam S.C.A. ($32.49M), and Samlyn Capital LLC ($30.10M).Learn more on BCYC's institutional investors.

What percentage of Bicycle Therapeutics stock is owned by institutional investors?

86.15% of Bicycle Therapeutics stock is owned by institutional investors. Learn more on BCYC's institutional investor holdings.

Which institutional investors have been buying Bicycle Therapeutics stock?

Of the 82 institutional investors that purchased Bicycle Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Deep Track Capital LP ($1.86M), Sio Capital Management LLC ($0.97M), Candriam S.C.A. ($0.96M), Samlyn Capital LLC ($0.87M), Armistice Capital LLC ($0.74M), Loomis Sayles & Co. L P ($0.64M), and Frazier Life Sciences Management L.P. ($0.60M).

How much institutional buying is happening at Bicycle Therapeutics?

Institutional investors have bought a total of 12,439,075 shares in the last 24 months. This purchase volume represents approximately $438.99M in transactions.

Which Bicycle Therapeutics major shareholders have been selling company stock?

Of the 57 institutional investors that sold Bicycle Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Point72 Asset Management L.P. ($1.17M), Tybourne Capital Management HK Ltd. ($1.01M), Logos Global Management LP ($0.69M), Victory Capital Management Inc. ($0.58M), Price T Rowe Associates Inc. MD ($0.37M), Two Sigma Investments LP ($0.33M), and First Light Asset Management LLC ($0.30M).

How much institutional selling is happening at Bicycle Therapeutics?

Institutional investors have sold a total of 6,930,359 shares in the last 24 months. This volume of shares sold represents approximately $199.50M in transactions.


Related Companies:
This page (NASDAQ:BCYC) was last updated on 9/23/2023 by MarketBeat.com Staff

My Account -